Evidence map›Paper›PMID 26909156›Full record

ArticleNew microbes and new infections2016

First case of Mycobacterium heckeshornense cavitary lung disease in the Latin America and Caribbean region.

C Coitinho, G Greif, J van Ingen, P Laserra, C Robello, C Rivas

Open access · goldAbstract readCase Reports
In one paragraph

Article in New microbes and new infections, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Asymptomatic pulmonaryIDCases · 2026
    Article
  2. Article
  3. HepaticThe Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Article
  4. Article
  5. Article
  6. A case of pulmonaryRespiratory medicine case reports · 2020
    Article
  7. Dust to Disease: Cavitary Lung Lesion WithJournal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

C CoitinhoComisión Honoraria de Lucha Anti-Tuberculosa y Enfermedades Prevalentes (CHLA-EP), Montevideo, Uruguay.
G GreifInstitut Pasteur de Montevideo, Montevideo, Uruguay.
J van IngenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
P LaserraComisión Honoraria de Lucha Anti-Tuberculosa y Enfermedades Prevalentes (CHLA-EP), Montevideo, Uruguay.
C RobelloInstitut Pasteur de Montevideo, Montevideo, Uruguay; Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
C RivasComisión Honoraria de Lucha Anti-Tuberculosa y Enfermedades Prevalentes (CHLA-EP), Montevideo, Uruguay.
Comisión Honoraria de Lucha contra el cáncer · UYInstitut Pasteur de Montevideo · UYRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A case of cavitary pulmonary disease caused by Mycobacterium heckeshornense in Uruguay is described. This is the first case reported in the Latin America and Caribbean region, showing that this species is a worldwide opportunistic human pathogen.

Indexed as

EpidemiologyinfectionmycobacteriumMycobacterium heckeshornensepulmonary

Identifiers

PMID26909156
PMCPMC4735480
OpenAlexW2251726056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.